These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

51 related items for PubMed ID: 17660663

  • 1. Infection in kidney transplant recipients in Tunisia.
    Charfeddine K, Kharrat M, Yaich S, Jarraya F, Mkawar K, Hachicha J.
    Saudi J Kidney Dis Transpl; 2002; 13(2):195-8. PubMed ID: 17660663
    [Abstract] [Full Text] [Related]

  • 2. Infectious complications in kidney transplant recipients: a single-center experience.
    Charfeddine K, Zaghden S, Kharrat M, Kamoun K, Jarraya F, Hachicha J.
    Transplant Proc; 2005; 37(6):2823-5. PubMed ID: 16182820
    [Abstract] [Full Text] [Related]

  • 3. One center's experience with antithymocyte globulin treatment for acute rejection in renal transplantation.
    Colak T, Sevmiş S, Karakayali H, Moray G, Haberal M.
    Transplant Proc; 2008; 40(1):123-5. PubMed ID: 18261564
    [Abstract] [Full Text] [Related]

  • 4. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM, Canafax DM, Gillingham KJ, Humar A, Pandian K, Kerr SR, Najarian JS, Matas AJ.
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [Abstract] [Full Text] [Related]

  • 5. OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients.
    Prieto M, Lake KD, Pritzker MR, Jorgensen CR, Arom KV, Love KR, Emery RW.
    J Heart Lung Transplant; 1991 Dec; 10(6):901-11. PubMed ID: 1661608
    [Abstract] [Full Text] [Related]

  • 6. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients.
    Wieneke H, Otte B, Lang D, Heidenreich S.
    Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953
    [Abstract] [Full Text] [Related]

  • 7. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ, Rossi AF, Courtney M, Gelb BD.
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.
    Ahsan N, Holman MJ, Yang HC.
    Clin Transplant; 1997 Dec; 11(6):633-9. PubMed ID: 9408699
    [Abstract] [Full Text] [Related]

  • 9. Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients.
    Snydman DR, Werner BG, Heinze-Lacey B, Berardi VP, Tilney NL, Kirkman RL, Milford EL, Cho SI, Bush HL, Levey AS.
    N Engl J Med; 1987 Oct 22; 317(17):1049-54. PubMed ID: 2821397
    [Abstract] [Full Text] [Related]

  • 10. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T, Kapischke M, Busing M.
    Transplant Proc; 2005 May 22; 37(4):1815-7. PubMed ID: 15919475
    [Abstract] [Full Text] [Related]

  • 11. Cytomegalovirus infection in renal transplant recipients.
    Carstens J, Andersen HK, Spencer E, Madsen M.
    Transpl Infect Dis; 2006 Dec 22; 8(4):203-12. PubMed ID: 17116133
    [Abstract] [Full Text] [Related]

  • 12. A prospective comparison of murine monoclonal CD-3 (OKT3) antibody-based and equine antithymocyte globulin-based rejection prophylaxis in cardiac transplantation. Decreased rejection and less corticosteroid use with OKT3.
    Renlund DG, O'Connell JB, Gilbert EM, Hammond ME, Burton NA, Jones KW, Karwande SV, Doty DB, Menlove RL, Herrick CM.
    Transplantation; 1989 Apr 22; 47(4):599-605. PubMed ID: 2523099
    [Abstract] [Full Text] [Related]

  • 13. Renal transplantation at Hartford Hospital: results of combined and flexible immunosuppression.
    Schweizer RT, Bow L, Roper L, Hull D, Bartus SA.
    Clin Transpl; 1988 Apr 22; ():147-58. PubMed ID: 3154467
    [Abstract] [Full Text] [Related]

  • 14. Prophylactic therapy for rejection after cardiac transplantation. A comparison of rabbit antithymocyte globulin and OKT3.
    Kirklin JK, Bourge RC, White-Williams C, Naftel DC, Thomas FT, Thomas JM, Phillips MG.
    J Thorac Cardiovasc Surg; 1990 Apr 22; 99(4):716-24. PubMed ID: 2108282
    [Abstract] [Full Text] [Related]

  • 15. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
    Cecka JM.
    Clin Transpl; 1997 Apr 22; ():1-14. PubMed ID: 9919387
    [Abstract] [Full Text] [Related]

  • 16. Infectious complications after simultaneous pancreas-kidney transplantation.
    Michalak G, Kwiatkowski A, Bieniasz M, Meszaros J, Czerwinski J, Wszola M, Nosek R, Ostrowski K, Chmura A, Danielewicz R, Lisik W, Adadynski L, Fesołowicz S, Dobrowolska A, Durlik M, Rowiñski W.
    Transplant Proc; 2005 Oct 22; 37(8):3560-3. PubMed ID: 16298661
    [Abstract] [Full Text] [Related]

  • 17. Acute rejection episodes in pediatric renal transplant recipients with cytomegalovirus infection.
    Kranz B, Vester U, Wingen AM, Nadalin S, Paul A, Broelsch CE, Hoyer PF.
    Pediatr Transplant; 2008 Jun 22; 12(4):474-8. PubMed ID: 18466436
    [Abstract] [Full Text] [Related]

  • 18. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.
    Cantarovich M, Latter DA, Loertscher R.
    Clin Transplant; 1997 Aug 22; 11(4):316-21. PubMed ID: 9267721
    [Abstract] [Full Text] [Related]

  • 19. Prophylactic use of OKT3 in immunologic high-risk cadaver renal transplant recipients.
    Schroeder TJ, First MR, Mansour ME, Alexander JW, Penn I.
    Am J Kidney Dis; 1989 Nov 22; 14(5 Suppl 2):14-8. PubMed ID: 2510506
    [Abstract] [Full Text] [Related]

  • 20. OKT3 prophylaxis in cadaveric kidney transplant recipients with delayed graft function.
    Cohen DJ, Benvenisty AI, Cianci J, Hardy MA.
    Am J Kidney Dis; 1989 Nov 22; 14(5 Suppl 2):19-27. PubMed ID: 2510507
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.